2019-842 Health - Walgreens drug dispense

Browse Search

WaArgF"Qi," 4 . 5 . 1 . 1 . Non - Eligible Patients With a Private Insurer. The drugs associated with the adjusted claim ( s ) shall be considered Non - Eligible 340B Drugs and Covered Entity shall not receive any amounts arising out of the Contracted Rate . To the extent Covered Entity previously received , or was credited for, any amounts arising out of the Contracted Rate , Covered Entity shall immediately remit such amounts to Walgreens or forfeit such credits . 4 . 5 . 1 . 2 . Non - Eligible Patients Without a Private Insurer . The drugs associated with the adjusted claim ( s ) shall be considered Non - Eligible 340B Drugs and Covered Entity shall reimburse Walgreens the difference between the Usual and Customary Charge and any amounts Walgreens has already received with respect to such Non - Eligible 340B Drugs . 4 . 5 . 2 . Deficient Replenishment : In the event Walgreens determines that the quantity of 340B Drugs provided to Walgreens is less than the quantity of 340B Drugs dispensed to Eligible Patients hereunder, Walgreens will notify Covered Entity and Covered Entity will instruct the Supplier to provide 340B Drugs to Walgreens . If, for whatever reason , the Supplier is unable to provide 340B Drugs as the 340B Drug ordered hereunder, Covered Entity will reimburse Walgreens for said drugs at the Inventory Replenishment Rate . 4 . 6 . Insurance . Walgreens will self- insure or maintain at its sole expense , and in amounts consistent with industry standards , insurance for general and professional liability and such other insurance as may be necessary to insure Walgreens , its employees , and agents against any claim or claims for damages arising directly or indirectly in connection with Walgreens ' negligent performance of any services under this Agreement , and the use of any property or facilities provided by Walgreens . Walgreens ' insurance information is available at www . walgreens . com / insurance . 5 . REIMBURSEMENT AND BILLING 5 . 1 . Invoice for Services . This Agreement is intended only to authorize Walgreens to perform the services described herein , and the parties acknowledge that Walgreens receives remuneration for performance of the services as set forth on Exhibit A . Walgreens will invoice Covered Entity on a monthly basis for all amounts arising under this Agreement during the previous calendar month ( " Invoice " ) . The Invoice will identify : ( i ) the number of prescriptions dispensed hereunder; ( ii ) any amounts due Walgreens including any and all fees , costs , charges , or reimbursement amounts , including but not necessarily limited to any amount arising out of the Tax, changes in the Supplier, Overdue Drugs , Aged Drugs , Slow Moving Drugs , 340B Pharmacy Services , Inventory Maintenance Services and a Reconciliation ( " Walgreens Balance " ) ; and ( iii ) any amounts due Covered Entity arising out of a Reconciliation or Exhibit A, if applicable ( "Covered Entity Balance " ) . 5 . 2 . Monthly Payments . If the Walgreens Balance is less than the Covered Entity Balance , Walgreens shall pay Covered Entity the difference between such amounts within thirty ( 30 ) calendar days from the Invoice date . Walgreens ' payment to Covered Entity shall be made via electronic funds transfer or to the location set forth in Section 8 . 11 of this Agreement . If the Covered Entity Balance is less than the Walgreens Balance , Covered Entity shall pay Walgreens the difference between such amounts through reconciliation or an invoice for direct payment within thirty ( 30 ) calendar days from the Invoice date . Covered Entity shall be solely responsible for tracking all amounts paid to Walgreens by invoice for direct payment . In the event Covered Entity anticipates that its cumulative direct payment ( s ) to Walgreens will exceed $ 10 , 000 ( the " Contract Dollar Amount " ) , Covered Entity will within fifteen ( 15 ) business days provide Walgreens with a written amendment to this Agreement limited to amending this 8 of 24 MAT- 63397 OrangeCountyHD - WAG 340E 10312019 ( be ) V1 . 0 © 2019 Walgreen Co . All rights reserved .